| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06358d32358b4ee4d23582c911bc6f2d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J3-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0710927fd9e19c6c64f87c26a9cd182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e403325713a473d677dfd0ed941ada14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185e9f6ded9049e94d71ba1f49993b50 |
| publicationDate |
2008-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7396827-B2 |
| titleOfInvention |
Pharmaceutical compositions and treatment methods |
| abstract |
The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, typically wherein the composition comprises less than about 3% water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16α-bromo-3β-hydroxy-5α-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen (viral) replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using certain steroids and steroid analogs. The invention also provides methods to make and use these immunomodulatory compositions and formulations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910571-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9716285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008015174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007275938-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11685762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008176824-A1 |
| priorityDate |
2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |